Home Search Abstracts Browse Oral Sessions Browse Poster Sessions
Session 150  Poster Abstracts
New Diagnostic and Monitoring Tools
Tuesday, 1-4 pm
Room: Hall B
      915 Enhanced Europium Nanoparticle-based Immunoassay for Sensitive and Early Detection of HIV-1 Capsid Antigen
Shixing Tang*1, J Zhao1, H Harma2, X Wang1, P Norris3, S Stramer4, and I Hewlett1
1Food and Drug Admin, Bethesda, MD, US; 2Univ of Turku, Finland; 3Blood Systems Res Inst, San Francisco, CA, US; and 4American Red Cross, Gaithersburg, MD, US
      916 HIV-1 Single-copy Assay Detects Biological Variation in Viremia in Patients Suppressed on ART
Nadia Urban*1, A Wiegand1, S Palmer1, J Mican2, A O'Shea2, C Rehm2, S Kottilil2, J Mellors3, J Coffin1, and F Maldarelli1
1HIV Drug Resistance Prgm NCI-Frederick, MD, US; 2Lab of Immunoregulation, NIAID, NIH, Bethesda, MD, US; and 3Univ of Pittsburgh, PA, US
      917 Accurate Representation of in vivo HIV-1 Quasispecies Plays an Important Role in the Quantification of Viral Tropism: A Comparison of 3 Different Methods to Generate env-Recombinant Viruses
J Weber1, K Henry2, R Gibson2, J Weberova1, A Vazquez1, E Arts2, and Miguel E Quinones-Mateu*1
1Diagnostic Hybrids Inc, Cleveland, OH, US and 2Case Western Reserve Univ, Cleveland, OH, US
      918 Usefulness of a Dendogram Plot Technique in Clustering Homogeneous Subgroups of Multi-treated HIV-1 Patients in Accordance with their Mutational Pattern
Nuria Perez-Alvarez*1,2, J Llibre1, B Clotet1,3, and the Conference Call Spanish Group
1Lluita contra la SIDA Fndn, Barcelona, Spain; 2Univ Politecnica de Catalunya, Barcelona, Spain; and 3IrsiCaixa Fndn, Barcelona, Spain
      919 SensiTrop QT: A Novel Molecular Diagnostic Assay for the Detection and Quantification of HIV Co-receptor Tropism
Wenhui Li*, E Webb, L Nary, and T Robins
Pathway Diagnostics, Malibu, CA, US
    920a Comparison of Results from the SensiTrop vs Trofile Assays on 100 Samples from the Maraviroc Expanded Access Program
Randall Tressler*1, H Valdez1, E van der Ryst2, I James2, M Lewis2, J Wheeler2, and S Than1
1Pfizer Inc, New York, NY, US and 2Pfizer Global R&D, Sandwich, UK
    920b High-quality Care Delivery in HIV by the Use of a Computerized Data System
John Zurlo*1, T Crook1, C Whitener1, D Greenawalt1, P Albright1, J Powers1, and J Quick2
1Penn State Univ, Hershey Med Ctr, Hershey, US and 2MajCo Svcs, Hershey, PA, US